RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Md Nurunnabi to Humans

Back to Details
This is a "connection" page, showing publications Md Nurunnabi has written about Humans.
Md Nurunnabi
Connection Strength
0.923
Humans
  1. Pena-Zacarias J, Zahid MI, Nurunnabi M. Electrochemical Nanosensor-Based Emerging Point-Of-Care Tools: Progress and Prospects. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024 Nov-Dec; 16(6):e2002.
    View in: PubMed
    Score: 0.041
  2. Gangavarapu A, Tapia-Lopez LV, Sarkar B, Pena-Zacarias J, Badruddoza AZM, Nurunnabi M. Lipid nanoparticles for enhancing oral bioavailability. Nanoscale. 2024 Oct 10; 16(39):18319-18338.
    View in: PubMed
    Score: 0.040
  3. Pearson RM, Nurunnabi M. Forum on Biomaterials for Immune and Gene Delivery. ACS Appl Bio Mater. 2024 08 19; 7(8):4816-4817.
    View in: PubMed
    Score: 0.040
  4. Diwan R, Bhatt HN, Dong R, Estevao IL, Varela-Ramirez A, Nurunnabi M. Cell selective BCL-2 inhibition enabled by lipid nanoparticles alleviates lung fibrosis. J Control Release. 2024 Jun; 370:421-437.
    View in: PubMed
    Score: 0.039
  5. Bhatt HN, Diwan R, Estevao IL, Dong R, Smith J, Xiao C, Agarwal SK, Nurunnabi M. Cadherin-11 targeted cell-specific liposomes enabled skin fibrosis treatment by inducing apoptosis. J Control Release. 2024 Jun; 370:110-123.
    View in: PubMed
    Score: 0.039
  6. Diwan R, Gaytan SL, Bhatt HN, Pena-Zacarias J, Nurunnabi M. Liver fibrosis pathologies and potentials of RNA based therapeutics modalities. Drug Deliv Transl Res. 2024 10; 14(10):2743-2770.
    View in: PubMed
    Score: 0.039
  7. Beaven E, Kumar R, An JM, Mendoza H, Sutradhar SC, Choi W, Narayan M, Lee YK, Nurunnabi M. Potentials of ionic liquids to overcome physical and biological barriers. Adv Drug Deliv Rev. 2024 01; 204:115157.
    View in: PubMed
    Score: 0.038
  8. Diwan R, Bhatt HN, Beaven E, Nurunnabi M. Emerging delivery approaches for targeted pulmonary fibrosis treatment. Adv Drug Deliv Rev. 2024 01; 204:115147.
    View in: PubMed
    Score: 0.038
  9. Afrin H, Geetha Bai R, Kumar R, Ahmad SS, Agarwal SK, Nurunnabi M. Oral delivery of RNAi for cancer therapy. Cancer Metastasis Rev. 2023 09; 42(3):699-724.
    View in: PubMed
    Score: 0.036
  10. Bhatt HN, Pena-Zacarias J, Beaven E, Zahid MI, Ahmad SS, Diwan R, Nurunnabi M. Potential and Progress of 2D Materials in Photomedicine for Cancer Treatment. ACS Appl Bio Mater. 2023 02 20; 6(2):365-383.
    View in: PubMed
    Score: 0.036
  11. Beaven E, Kumar R, Bhatt HN, Esquivel SV, Nurunnabi M. Myofibroblast specific targeting approaches to improve fibrosis treatment. Chem Commun (Camb). 2022 Dec 08; 58(98):13556-13571.
    View in: PubMed
    Score: 0.036
  12. Kumar R, Islam T, Nurunnabi M. Mucoadhesive carriers for oral drug delivery. J Control Release. 2022 11; 351:504-559.
    View in: PubMed
    Score: 0.035
  13. Afrin H, Huda MN, Islam T, Oropeza BP, Alvidrez E, Abir MI, Boland T, Turbay D, Nurunnabi M. Detection of Anticancer Drug-Induced Cardiotoxicity Using VCAM1-Targeted Nanoprobes. ACS Appl Mater Interfaces. 2022 Aug 24; 14(33):37566-37576.
    View in: PubMed
    Score: 0.035
  14. Huda MN, Deaguero IG, Borrego EA, Kumar R, Islam T, Afrin H, Varela-Ramirez A, Aguilera RJ, Tanner EEL, Nurunnabi M. Ionic liquid-mediated delivery of a BCL-2 inhibitor for topical treatment of skin melanoma. J Control Release. 2022 09; 349:783-795.
    View in: PubMed
    Score: 0.035
  15. Huda MN, Nurunnabi M. Potential Application of Exosomes in Vaccine Development and Delivery. Pharm Res. 2022 Nov; 39(11):2635-2671.
    View in: PubMed
    Score: 0.033
  16. Islam T, Huda MN, Ahsan MA, Afrin H, Joseph J Salazar C, Nurunnabi M. Theoretical and Experimental Insights into the Possible Interfacial Interactions between ?-Glucan and Fat Molecules in Aqueous Media. J Phys Chem B. 2021 12 23; 125(50):13730-13743.
    View in: PubMed
    Score: 0.033
  17. Chowdhury MMH, Salazar CJJ, Nurunnabi M. Recent advances in bionanomaterials for liver cancer diagnosis and treatment. Biomater Sci. 2021 Jul 13; 9(14):4821-4842.
    View in: PubMed
    Score: 0.032
  18. Nurunnabi M, Ibsen KN, Tanner EEL, Mitragotri S. Reply to Peiretti et al.: Effect of CAGE on fat uptake and food intake. Proc Natl Acad Sci U S A. 2020 04 14; 117(15):8249.
    View in: PubMed
    Score: 0.029
  19. Nurunnabi M, Lee SA, Revuri V, Hwang YH, Kang SH, Lee M, Cho S, Cho KJ, Byun Y, Bae YH, Lee DY, Lee YK. Oral delivery of a therapeutic gene encoding glucagon-like peptide 1 to treat high fat diet-induced diabetes. J Control Release. 2017 Dec 28; 268:305-313.
    View in: PubMed
    Score: 0.025
  20. Nurunnabi M, Nafiujjaman M, Lee SJ, Park IK, Huh KM, Lee YK. Preparation of ultra-thin hexagonal boron nitride nanoplates for cancer cell imaging and neurotransmitter sensing. Chem Commun (Camb). 2016 04 26; 52(36):6146-9.
    View in: PubMed
    Score: 0.022
  21. Nurunnabi M, Khatun Z, Reeck GR, Lee DY, Lee YK. Photoluminescent graphene nanoparticles for cancer phototherapy and imaging. ACS Appl Mater Interfaces. 2014 Aug 13; 6(15):12413-21.
    View in: PubMed
    Score: 0.020
  22. Nurunnabi M, Khatun Z, Huh KM, Park SY, Lee DY, Cho KJ, Lee YK. In vivo biodistribution and toxicology of carboxylated graphene quantum dots. ACS Nano. 2013 Aug 27; 7(8):6858-67.
    View in: PubMed
    Score: 0.019
  23. Nurunnabi M, Khatun Z, Reeck GR, Lee DY, Lee YK. Near infra-red photoluminescent graphene nanoparticles greatly expand their use in noninvasive biomedical imaging. Chem Commun (Camb). 2013 Jun 04; 49(44):5079-81.
    View in: PubMed
    Score: 0.018
  24. Nurunnabi M, Cho KJ, Choi JS, Huh KM, Lee YK. Targeted near-IR QDs-loaded micelles for cancer therapy and imaging. Biomaterials. 2010 Jul; 31(20):5436-44.
    View in: PubMed
    Score: 0.015
  25. Mondal J, Chakraborty K, Bunggulawa EJ, An JM, Revuri V, Nurunnabi M, Lee YK. Recent advancements of hydrogels in immunotherapy: Breast cancer treatment. J Control Release. 2024 Aug; 372:1-30.
    View in: PubMed
    Score: 0.010
  26. Biswas M, Nurunnabi M, Khatun Z. Understanding Mucosal Physiology and Rationale of Formulation Design for Improved Mucosal Immunity. ACS Appl Bio Mater. 2024 08 19; 7(8):5037-5056.
    View in: PubMed
    Score: 0.010
  27. Chung SJ, Hadrick K, Nafiujjaman M, Apu EH, Hill ML, Nurunnabi M, Contag CH, Kim T. Targeted Biodegradable Near-Infrared Fluorescent Nanoparticles for Colorectal Cancer Imaging. ACS Appl Bio Mater. 2024 12 16; 7(12):7861-7870.
    View in: PubMed
    Score: 0.010
  28. Kumar J, Karim A, Sweety UH, Sarma H, Nurunnabi M, Narayan M. Bioinspired Approaches for Central Nervous System Targeted Gene Delivery. ACS Appl Bio Mater. 2024 08 19; 7(8):4975-4997.
    View in: PubMed
    Score: 0.010
  29. Knipe RS, Nurunnabi M, Probst CK, Spinney JJ, Abe E, Bose RJC, Ha K, Logue A, Nguyen T, Servis R, Drummond M, Haring A, Brazee PL, Medoff BD, McCarthy JR. Myofibroblast-specific inhibition of the Rho kinase-MRTF-SRF pathway using nanotechnology for the prevention of pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol. 2023 02 01; 324(2):L190-L198.
    View in: PubMed
    Score: 0.009
  30. Gonzalez MA, Olivas IM, Bencomo-Alvarez AE, Rubio AJ, Barreto-Vargas C, Lopez JL, Dang SK, Solecki JP, McCall E, Astudillo G, Velazquez VV, Schenkel K, Reffell K, Perkins M, Nguyen N, Apaflo JN, Alvidrez E, Young JE, Lara JJ, Yan D, Senina A, Ahmann J, Varley KE, Mason CC, Eide CA, Druker BJ, Nurunnabi M, Padilla O, Bajpeyi S, Eiring AM. Loss of G0/G1 switch gene 2 (G0S2) promotes disease progression and drug resistance in chronic myeloid leukaemia (CML) by disrupting glycerophospholipid metabolism. Clin Transl Med. 2022 12; 12(12):e1146.
    View in: PubMed
    Score: 0.009
  31. Dubey P, Thakur B, Reddy S, Martinez CA, Nurunnabi M, Manuel SL, Chheda S, Bracamontes C, Dwivedi AK. Current trends and geographical differences in therapeutic profile and outcomes of COVID-19 among pregnant women - a systematic review and meta-analysis. BMC Pregnancy Childbirth. 2021 Mar 24; 21(1):247.
    View in: PubMed
    Score: 0.008
  32. Islam T, Hasan MM, Awal A, Nurunnabi M, Ahammad AJS. Metal Nanoparticles for Electrochemical Sensing: Progress and Challenges in the Clinical Transition of Point-of-Care Testing. Molecules. 2020 Dec 08; 25(24).
    View in: PubMed
    Score: 0.008
  33. Sun T, Dasgupta A, Zhao Z, Nurunnabi M, Mitragotri S. Physical triggering strategies for drug delivery. Adv Drug Deliv Rev. 2020; 158:36-62.
    View in: PubMed
    Score: 0.008
  34. Kim Y, Uthaman S, Nurunnabi M, Mallick S, Oh KS, Kang SW, Cho S, Kang HC, Lee YK, Huh KM. Synthesis and characterization of bioreducible cationic biarm polymer for efficient gene delivery. Int J Biol Macromol. 2018 Apr 15; 110:366-374.
    View in: PubMed
    Score: 0.006
  35. Kim J, Nafiujjaman M, Nurunnabi M, Lim S, Lee YK, Park HK. Effects of polymer-coated boron nitrides with increased hemorheological compatibility on human erythrocytes and blood coagulation. Clin Hemorheol Microcirc. 2018; 70(3):241-256.
    View in: PubMed
    Score: 0.006
  36. Cherukula K, Nurunnabi M, Jeong YY, Lee YK, Park IK. A targeted graphene nanoplatform carrying histamine dihydrochloride for effective inhibition of leukemia-induced immunosuppression. J Biomater Sci Polym Ed. 2018 May - Jun; 29(7-9):734-749.
    View in: PubMed
    Score: 0.006
  37. Khatun Z, Choi YS, Kim YG, Yoon K, Nurunnabi M, Li L, Lee E, Kang HC, Huh KM. Bioreducible Poly(ethylene glycol)-Triphenylphosphonium Conjugate as a Bioactivable Mitochondria-Targeting Nanocarrier. Biomacromolecules. 2017 04 10; 18(4):1074-1085.
    View in: PubMed
    Score: 0.006
  38. Lee DY, Nurunnabi M, Kang SH, Nafiujjaman M, Huh KM, Lee YK, Kim YC. Oral Gavage Delivery of PR8 Antigen with ?-Glucan-Conjugated GRGDS Carrier to Enhance M-Cell Targeting Ability and Induce Immunity. Biomacromolecules. 2017 04 10; 18(4):1172-1179.
    View in: PubMed
    Score: 0.006
  39. Kim J, Nafiujjaman M, Nurunnabi M, Lee YK, Park HK. Hemorheological characteristics of red blood cells exposed to surface functionalized graphene quantum dots. Food Chem Toxicol. 2016 Nov; 97:346-353.
    View in: PubMed
    Score: 0.006
  40. Khatun Z, Nurunnabi M, Nafiujjaman M, Reeck GR, Khan HA, Cho KJ, Lee YK. A hyaluronic acid nanogel for photo-chemo theranostics of lung cancer with simultaneous light-responsive controlled release of doxorubicin. Nanoscale. 2015 Jun 28; 7(24):10680-9.
    View in: PubMed
    Score: 0.005
  41. Nafiujjaman M, Revuri V, Nurunnabi M, Cho KJ, Lee YK. Photosensitizer conjugated iron oxide nanoparticles for simultaneous in vitro magneto-fluorescent imaging guided photodynamic therapy. Chem Commun (Camb). 2015 Apr 04; 51(26):5687-90.
    View in: PubMed
    Score: 0.005
  42. Hasan A, Nurunnabi M, Morshed M, Paul A, Polini A, Kuila T, Al Hariri M, Lee YK, Jaffa AA. Recent advances in application of biosensors in tissue engineering. Biomed Res Int. 2014; 2014:307519.
    View in: PubMed
    Score: 0.005
  43. Khatun Z, Nurunnabi M, Reeck GR, Cho KJ, Lee YK. Oral delivery of taurocholic acid linked heparin-docetaxel conjugates for cancer therapy. J Control Release. 2013 Aug 28; 170(1):74-82.
    View in: PubMed
    Score: 0.005
  44. Khatun Z, Nurunnabi M, Cho KJ, Lee YK. Oral delivery of near-infrared quantum dot loaded micelles for noninvasive biomedical imaging. ACS Appl Mater Interfaces. 2012 Aug; 4(8):3880-7.
    View in: PubMed
    Score: 0.004
  45. Khatun Z, Nurunnabi M, Cho KJ, Lee YK. Imaging of the GI tract by QDs loaded heparin-deoxycholic acid (DOCA) nanoparticles. Carbohydr Polym. 2012 Nov 06; 90(4):1461-8.
    View in: PubMed
    Score: 0.004
  46. Kim JS, Cho KJ, Tran TH, Nurunnabi M, Moon TH, Hong SM, Lee YK. In vivo NIR imaging with CdTe/CdSe quantum dots entrapped in PLGA nanospheres. J Colloid Interface Sci. 2011 Jan 15; 353(2):363-71.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support